- Home
- LVWR vs ADCT Comparison
LVWR vs ADCT Comparison
Compare LVWR & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- ADCT
- Stock Information
- Founded
- LVWR 2022
- ADCT 2011
- Country
- LVWR United States
- ADCT Switzerland
- Employees
- LVWR N/A
- ADCT N/A
- Industry
- LVWR
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- LVWR
- ADCT Health Care
- Exchange
- LVWR Nasdaq
- ADCT Nasdaq
- Market Cap
- LVWR 205.6M
- ADCT 241.0M
- IPO Year
- LVWR N/A
- ADCT 2020
- Fundamental
- Price
- LVWR $3.18
- ADCT $3.25
- Analyst Decision
- LVWR
- ADCT Strong Buy
- Analyst Count
- LVWR 0
- ADCT 6
- Target Price
- LVWR N/A
- ADCT $7.80
- AVG Volume (30 Days)
- LVWR 523.4K
- ADCT 880.7K
- Earning Date
- LVWR 07-24-2025
- ADCT 08-05-2025
- Dividend Yield
- LVWR N/A
- ADCT N/A
- EPS Growth
- LVWR N/A
- ADCT N/A
- EPS
- LVWR N/A
- ADCT N/A
- Revenue
- LVWR $24,398,000.00
- ADCT $75,817,000.00
- Revenue This Year
- LVWR $249.13
- ADCT $11.75
- Revenue Next Year
- LVWR $98.53
- ADCT $10.29
- P/E Ratio
- LVWR N/A
- ADCT N/A
- Revenue Growth
- LVWR N/A
- ADCT 10.49
- 52 Week Low
- LVWR $0.93
- ADCT $1.05
- 52 Week High
- LVWR $9.04
- ADCT $4.13
- Technical
- Relative Strength Index (RSI)
- LVWR 37.66
- ADCT 58.36
- Support Level
- LVWR $3.12
- ADCT $3.02
- Resistance Level
- LVWR $4.11
- ADCT $3.39
- Average True Range (ATR)
- LVWR 0.39
- ADCT 0.22
- MACD
- LVWR -0.26
- ADCT 0.03
- Stochastic Oscillator
- LVWR 4.40
- ADCT 83.23
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).